Retatrutide (10mg) – Aussie Peptides
🔥 One of the most powerful triple agonist peptides on the research market.
$150.00 AUD
Product Overview
Retatrutide is a novel investigational peptide designed as a triple agonist targeting GLP-1, GIP, and glucagon receptors. It has emerged as a compound of interest in metabolic research due to its multifaceted role in energy balance, glucose homeostasis, and lipid metabolism.
Each vial contains 10mg of lyophilized Retatrutide, formulated for precise, controlled dilution under appropriate lab conditions.
Specifications
Research Background
Retatrutide represents a significant advancement in metabolic research peptides, with emerging data highlighting its unique triple-agonist mechanism. These observations are from third-party scientific studies and are provided for informational purposes only:
Weight Management
Participants in clinical studies have shown up to 24.2% body weight reduction over 48 weeks at higher doses. This substantial effect is believed to be due to the synergistic action across multiple metabolic pathways simultaneously.
Source: JAMA Network, 2023
Glucose and Insulin Sensitivity Support
Improved insulin sensitivity and reduced fasting glucose were observed in pre-diabetic individuals during controlled trials. The peptide's action on multiple receptors appears to provide complementary mechanisms for glucose metabolism regulation.
Source: Nature Medicine, 2022
Appetite and Energy Regulation
Enhanced satiety signals were documented, likely due to GLP-1 and GIP pathway synergy. This effect, combined with glucagon's metabolic actions, suggests a multifaceted approach to energy balance regulation in experimental models.
Source: The New England Journal of Medicine
Suggested Research Application
While dosage and reconstitution may vary depending on experimental conditions, studies typically explored low microgram-range administration 1–2 times per week. Storage should be at -20°C for long-term preservation.
Reconstituted peptides should be handled using sterile laboratory techniques and maintained at 2-8°C for short-term use. For optimal stability, minimize freeze-thaw cycles and exposure to light or extreme pH conditions.
Important Notice
This product is NOT a therapeutic good as defined by the Therapeutic Goods Act 1989. It is not intended for human use or ingestion. For laboratory, educational, and scientific research purposes only. Use in animals or humans is strictly prohibited unless explicitly approved by a relevant authority.
Related Products
Semaglutide (5mg)
Long-acting GLP-1 receptor agonist for metabolic research.
$195.00 AUD
Cagrilintide (10mg)
Long-acting amylin analogue for metabolic research.
$220.00 AUD
HGH (10IU)
Human Growth Hormone for metabolic research.
$125.00 AUD